NAUT FY 2021 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$50M

Net Income

-$50M

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$42M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$398M

Total Liabilities

$35M

Stockholders' Equity

$364M

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$2M	-21.1%
Operating Income	-$50M	-$16M	-220.7%
Net Income	-$50M	-$16M	-222.1%